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1. Introduction 
The intestinal epithelium is a very dynamic tissue, being completely renewed over a 3-5 day 
period in the human. Epithelial cells in the intestine lie on a specialized layer of extracellular 
matrix material referred to as the basement membrane (BM). Intestinal epithelial cell 
interactions with BM molecules such as collagens, laminins, fibronectin and tenascin 
regulate crucial functions of the normal intestinal epithelial renewal process such as cell 
adhesion, migration, signalization and gene expression as well as anoikis. BM molecules can 
be secreted by epithelial cells but a number of them are exclusively synthesized and 
deposited by the subepithelial myofibroblasts. In this chapter, we will review alterations at 
the epithelial-stromal interface in Crohn's disease (CD) with a specific emphasis on 
epithelial cell and myofibroblast susceptibility to proinflammatory cytokines in the crypt 
region.  
2. Epithelial BM molecules in the normal human intestine 
The epithelial BM of the human intestine has been found to contain all the major 
components specific to most basement membranes as well as a number of non-exclusive BM 
components. There is good evidence that both types of BM components play an active role 
in intestinal epithelial cell biology through their interaction with specific cell membrane 
integrin and non-integrin receptors, which mediate cell adhesion, migration, cell cycle and 
gene expression. Current knowledge about epithelial BM composition in the normal human 
intestine is summarized below. More detailed information on BM molecules and their 
receptors in the intestine can be found elsewhere (Beaulieu 1997a, Beaulieu 2001, Lussier et 
al. 2000, Ménard et al. 2006, Teller&Beaulieu 2001). 
2.1 Exclusive and non-exclusive BM components   
As illustrated in Figure 1, exclusive BM components include the type IV collagens and 
laminins. These macromolecules are complex protein families composed of various sub-
units. Detailed analysis of various genetic forms of type IV collagens and laminins revealed 
the presence of at least two distinct types of type IV collagen heterotrimers based on the 
expression of the 1(IV)/2(IV) and 5(IV)/6(IV) chains (Beaulieu 1992, Beaulieu et al. 
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1994, Simoneau et al. 1998) and the 4 main laminins, LM-111, LM-211, LM-332 and LM-511 
(Beaulieu 1992, Beaulieu&Vachon 1994, Teller et al. 2007).  
A second interesting feature of the intestinal epithelial BM is the presence of a relatively 
large number of non-exclusive BM components, such as fibronectin, tenascin-C, osteopontin 
and type VI collagen that have been found to be integral epithelial BM components 
(Aufderheide&Ekblom 1988, Beaulieu et al. 1991, Beaulieu 1992, Groulx et al. 2011, Simon-
Assmann et al. 1990b) although they can be found also in the underlying interstitial matrix 
(Fig.1). 
 
 
Fig. 1. The intestinal epithelial BM. The BM, which is located at the interface between the 
epithelial cells (e) and the subepithelial myofibroblasts (m), contains BM-specific 
macromolecules (e.g. type IV collagens and laminins) as well as non-exclusive BM 
components (e.g. tenascin-C and type VI collagen). Both types of components can originate 
from the epithelial cells and/or the subepithelial myofibroblasts (white arrows).  
The third interesting phenomenon relative to the epithelial BM in the intestine is the dual 
tissular origin of the BM components. Indeed, while the type IV collagen 5(IV) and 6(IV) 
chains as well as type VI collagen are expressed at least in part by epithelial cells, the major 
type IV collagen chains 1(IV) and 2(IV) are exclusively of stromal origin (Beaulieu et al. 
1994, Groulx et al. 2011, Simon-Assmann et al. 1990a, Simoneau et al. 1998, Vachon et al. 
1993), presumably synthesized by the subepithelial myofibroblasts (Fig. 1). Analysis of the 
tissular origin of the laminins also revealed dual epithelial/stromal origin for laminins LM-
111 and LM-332 (epithelial), LM211 (stromal) and LM511 (both) (Perreault et al. 1998, Teller 
et al. 2007). 
2.2 Spatial and temporal BM microenvironments   
Spatial and temporal patterns of expression for BM components in the intact intestinal 
epithelium have been very informative in evaluating the potential role of individual 
macromolecules in the regulation of cell functions, most notably cell growth and 
differentiation, under a normal environment. Indeed, during development, the process of 
endodermal differentiation into a functional epithelium coincides with the morphogenesis 
of the villi and the crypts in both the small and large intestines. In the mature intestine, the 
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epithelial renewing units consist of spatially well-separated proliferative and differentiated 
cell populations. Furthermore, the renewing units differ along the proximal-distal gradient, 
the crypt-to-villus axis of the small intestine being replaced by a gland-to-surface epithelial 
axis in the colon (Beaulieu 1997b, Ménard&Beaulieu 1994, Ménard et al. 2006) (Fig. 2). 
 
 
Fig. 2. Development and characteristics of the epithelium in the human small and large 
intestines. The human intestine develops relatively early during ontogeny. Villi develop 
between 9 and 11 weeks of gestation while crypts form around 16 weeks so that typical 
adult-like crypt-villus architecture is already established in the small intestine at mid-
gestation (18 to 20 weeks). Similar crypt-villus architecture is transitorily present in the 
developing colon up to mid-gestation. However, at birth, the villi have disappeared and the 
typical adult gland-to-surface epithelial architecture has been established (proximal-distal 
gradient). At maturity, the proliferative cell populations responsible for the renewing of the 
epithelium are located in the lower ⅔ of the small intestinal crypts and the lower ½ of the 
colonic glands. The functional cells of these renewing units are located on the villus and the 
surface epithelium of the small and large intestines, respectively (Adapted from 
(Teller&Beaulieu 2001).  
3. Alterations of epithelial BM composition in CD 
Alterations of epithelial BM composition have been reported in various intestinal 
pathologies (Belanger&Beaulieu 2000, Teller&Beaulieu 2001). Although none of these 
alterations has yet been demonstrated to be the primary defect in any intestinal disease, they 
are not exclusively secondary to the disruption of the epithelial-stromal interface. In 
colorectal cancers for instance, laminin alterations are thought to play an active role in 
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invasion (Lohi 2001). Alteration in the distribution and/or expression of BM molecules were 
also observed in other intestinal pathologies such as tufting enteropathy (Goulet et al. 1995) 
and chronic inflammatory bowel conditions (Bouatrouss 1998). The alterations in the 
epithelial BM composition in the context of inflammatory bowel disease pathogenesis and as 
potential disease indicators will now be discussed. 
3.1 BM components in the crypts of inflamed specimens from CD patients    
Although clinically distinct, chronic inflammatory bowel diseases such as CD and ulcerative 
colitis share common histopathological features including mucosal inflammation, villous 
atrophy, crypt hypertrophy and epithelial cell injury (Chadwick 1991).  
In CD, an important redistribution of laminins was observed at the epithelial-stromal 
interface of inflamed specimens as compared to non-inflamed specimens from the same 
patients (Bouatrouss et al. 2000). First, the crypt specific laminin, LM-211, was found to be 
essentially absent from the mucosa. Second, two other laminins, LM-332 and LM-511, 
remained strongly expressed in the epithelial BM of the atrophied and inflamed villi. 
However, a significant upregulation of both LM-332 and LM-511 expression was observed 
in the lower crypts of inflamed CD specimens. Furthermore, a significant reduction in the 
levels of tenascin-C was also observed in the crypt region of inflamed CD specimens 
(Francoeur et al. 2009). Incidentally, the intestinal mucosa is among the few sites where 
tenascin-C remains expressed in adulthood (Belanger&Beaulieu 2000). Interestingly, in 
ulcerative colitis, most of the epithelial BM surrounding the glands has been found to be 
devoid of immunoreactive laminin (Schmehl et al. 2000) and tenascin-C (Francoeur et al. 
2009) in actively affected colonic tissues. Also, alterations in laminin and tenascin-C 
expression were not observed in celiac disease (Korhonen et al. 2000), an immune-mediated 
intestinal pathology that is also characterized by villus atrophy and crypt hyperplasia 
(Maki&Collin 1997), suggesting that the redistribution of laminins and tenascin-C in CD 
could be related to the chronic inflammatory condition. 
From these studies, it can be concluded that important alterations in epithelial BM molecule 
expression occur in the intestinal mucosa of patients with inflammatory bowel diseases. The 
fact that these alterations appear to be mainly confined to the crypts in these diseases, as 
summarized for CD in Fig. 3, suggests that compositional changes in the crypt epithelial BM 
may be of functional importance in the pathogenesis of these afflictions. 
3.2 Effects of proinflammatory cytokines on human intestinal epithelial crypt cells    
One of the landmarks of inflammatory bowel conditions such as CD is the chronic 
imbalance between immunoregulatory and proinflammatory cytokines (Bouma&Strober 
2003, Fiocchi 1997a, MacDonald&Monteleone 2006, Sartor 2006). Among the cytokines most 
frequently found to be elevated in the inflamed CD mucosa are interleukin-1 and 6 (IL-1 
and IL-6), tumor necrosis factor  (TNF) and interferon  (IFN). Because they represent 
the main component of the intestinal barrier, epithelial cells have been one of the 
nonimmune cell types most extensively studied in inflammatory bowel diseases. While 
morphological and functional alterations in epithelial integrity were described several years 
ago (Dvorak&Dickersin 1980, Hollander 1993), more recent work has provided evidence 
that these changes are primarily mediated by cytokines released from adjacent 
inflammatory cells as well as from the epithelial cells themselves (Abraham&Medzhitov 
2011, Dionne et al. 1999, Fiocchi 1997b, McKay&Baird 1999, Podolsky 2000).  
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Fig. 3. Alterations of epithelial BM composition in the human intestinal mucosa under 
normal vs inflammatory conditions. In the normal small intestine (left), laminins LM-322 
and LM-511 are found in the BM of the villus epithelial cells while laminin LM-211, is found 
in the BM of crypt epithelial cells. Tenascin-C (Tn-C) is found in the epithelial BM of both 
the crypts and villi. LM-332 and LM-511 of the epithelial BM are mainly produced by 
epithelial cells (E) while LM-211 and Tn-C are synthesized by the sub-epithelial 
myofibroblasts (SEMF). In inflamed CD specimens (inflammatory conditions), laminins LM-
332 and LM-511 remain expressed by epithelial cells of the atrophied villi while in the 
crypts, the other laminin, LM-211, as well as most of the Tn-C at the epithelial BM are lost 
and replaced by the neo-expression of laminins LM-332 and LM-511. Functionally, these 
events are associated with pro-inflammatory cytokines which a) stimulate LM-332 and LM-
511 production by crypt epithelial cells and b) induce apoptosis and de-differentiation of the 
sub-epithelial myofibroblasts (see sections 3.2 and 3.3 and Fig. 4 for more details).         
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Considering that changes in BM composition under inflammatory conditions are mainly 
observed in the lower part of the crypt (Fig. 3), our laboratory investigated the effect of 
proinflammatory cytokines on laminin expression in human intestinal epithelial cells using 
the well-characterized human intestinal epithelial crypt (HIEC) cell line as an experimental 
cell model representative of the human intestinal lower crypt (Benoit et al. 2010, Pageot et al. 
2000, Quaroni&Beaulieu 1997). Individually, all tested cytokines including IL-1, IL-6, TNF 
and IFN as well as transforming growth factor  (TGF) exerted relatively modest effects 
on laminin LM-332 and LM-511 production in HIEC cells. However in combination, a 
synergistic effect of TNF and IFN was observed on both laminin LM-332 and LM-511 
production at protein and transcript levels (Francoeur et al. 2004). TNF and IFN synergy 
has also been reported in various intestinal epithelial cell models for chemokine production 
(Warhurst et al. 1998), alteration in epithelial barrier properties (Wang et al. 2006), and 
acquisition of susceptibility to Fas-induced apoptosis (Begue et al. 2006, Ruemmele et al. 
1999). The TNF/IFN combination was also found to synergistically induce caspase-
dependent apoptosis in HIEC cells (Francoeur et al. 2004). Interestingly, caspase inhibitors 
completely prevented TNF/IFN-induced apoptosis but did not influence the induction of 
laminin expression indicating that the two events occurred independently.  
The contribution of TGF in the synergistic effects of TNF/IFN on laminin production 
was investigated in light of the fact that levels of TGF have been reported to be elevated in 
the mucosa of CD patients (Babyatsky et al. 1996) and that this multifunctional cytokine can 
exert a crucial function on intestinal epithelial wound healing (Podolsky 2000), in part 
through its ability to stimulate extracellular matrix molecule expression 
(Verrecchia&Mauviel 2002). Indeed, in rodent intestinal crypt cells, the promotion of 
epithelial healing by specific cytokines such as IL-1, IFN and TGF was found to act 
under a bioactive TGF dependent mechanism (Dignass&Podolsky 1993). However, TGF 
was found to be significantly less potent than the TNF/IFN combination in human 
intestinal crypt cells on laminin production suggesting a TGF-independent mechanism 
(Francoeur et al. 2004). 
In summary, the two proinflammatory cytokines TNF and IFN synergistically induce the 
expression of the specific BM molecules, laminin LM-332 and LM-511, in human intestinal 
crypt cells. The synergistic effect of the TNF/IFN combination on laminin production was 
found to be independent of the effect of these cytokines on cell apoptosis and appears to be 
controlled by an apparent TGF-independent mechanism.  
3.3 Effects of proinflammatory cytokines on human pericryptal subepithelial 
myofibroblasts   
Along with the epithelial cells, myofibroblasts are another important nonprofessional immune 
mucosal cell type for which evidence supports a participation in the pathogenesis of 
inflammatory bowel diseases (Fiocchi 1997b, Macdonald&Monteleone 2005). The 
myofibroblast  is an intermediate cell type between the smooth muscle cell and the fibroblast 
that is characterized by alpha smooth muscle actin (SMA) and vimentin expression (Gabbiani 
2003). While there is evidence that intramucosal myofibroblasts can be involved in CD 
(Vallance et al. 2005), it is the intestinal subepithelial myofibroblasts present immediately 
subjacent to the epithelial BM (Powell et al. 2005) in the form of a pericryptal sheath that have 
been the primary focus of attention in the pathogenesis of inflammatory bowel diseases. 
Because of their vicinity to the basal surface of epithelial cells, they are potential targets for 
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bacteria and their products deposited in the subepithelial compartment when the epithelial 
barrier is disrupted. In turn, when stimulated, myofibroblasts can release various cytokines 
and chemokines (Fiocchi 1997b, Powell et al. 1999, Powell et al. 2005) and extracellular matrix 
molecules (Riedl et al. 1992) suggesting that intestinal subepithelial myofibroblasts can 
participate in the innate immune response (Otte et al. 2003, Saada et al. 2006). Furthermore, the 
subepithelial myofibroblast represents a key component of epithelial-stromal interactions in 
the intestine (Ménard et al. 2006, Powell et al. 2005), which can regulate both basic and healing 
epithelial cell functions through the secretion of paracrine factors such as the Wnts, BMPs, and 
TGF, which target epithelial cells (Ménard et al. 2006, Powell et al. 2005), the release of 
proteinases (Kruidenier et al. 2006, McKaig et al. 2003) and the production of extracellular 
matrix molecules that contribute to the epithelial BM such as laminin LM-211 and tenascin-C 
(Beaulieu 1997a, Perreault et al. 1998, Riedl et al. 1992, Teller et al. 2007, Vachon et al. 1993). 
Analysis of subepithelial myofibroblast characteristics in inflamed small intestinal mucosa of 
CD patients revealed a number of alterations in the crypt region (Francoeur et al. 2009). First, a 
disappearance of SMA positive cells was observed in a large proportion of the crypts while in 
others, the SMA cellular staining was abnormally thick and co-stained by desmin suggesting 
a reorganization/redifferentiation into smooth muscle cells. Characterization of the pericryptal 
myofibroblastic sheath in the colonic mucosa from patients with various pathologic conditions 
including CD, ulcerative colitis, acute infectious colitis and noninfectious colitis confirmed the 
disappearance of SMA positive cells (also desmin negative) in the inflamed mucosa from 
inflammatory bowel diseases but not in other pathological conditions. Analysis of the 
expression of tenascin-C, which is exclusively produced by the myofibroblasts and muscle 
cells of the human intestine (Belanger&Beaulieu 2000) in the crypt epithelial BM revealed a 
close correlation between myofibroblast disappearance (loss of normal SMA staining) and 
loss of tenascin-C staining (Francoeur et al. 2009). The significant reduction of SMA positive 
cells in the pericryptal region concomitant with a disappearance of tenascin-C (Francoeur et al. 
2009) and laminin LM-211 (Bouatrouss et al. 2000) suggested that pericryptal myofibroblasts 
are lost in the inflamed mucosa of CD patients.  
To test this hypothesis, we used various preparations of myofibroblastic cells isolated from 
the human intestinal mucosa (Pinchuk et al. 2007, Teller et al. 2007, Vachon et al. 1993) as 
experimental cell models. Myofibroblasts are known to respond to various inflammatory 
signals (Otte et al. 2003, Saada et al. 2006) and have been shown to be altered in 
inflammatory bowel diseases (Fiocchi 1997b, Powell et al. 1999, Powell et al. 2005). For 
instance, mesenchymal cells isolated from the inflamed mucosa show higher levels of 
collagen production than their normal counterparts. We thus investigated the possibility 
that a loss of pericryptal myofibroblasts occurs in the inflamed regions of CD mucosa by 
testing myofibroblast susceptibility to the same panel of proinflammatory cytokines used 
above for epithelial cells (section 3.2). Individually, IL-1, IL-6, TNF and IFN as well as 
TGF exerted little or no effect on the growth and survival of intestinal myofibroblasts. 
However, cytokine combinations containing TNF and IFN induced significant caspase-
dependent apoptosis, suggesting that this mechanism may account for the loss of 
myofibroblasts in the inflamed CD mucosa. While not yet reported for myofibroblasts, the 
synergistic effect of TNF/IFN on various functions has been described in other cell types, 
namely intestinal epithelial cells (Begue et al. 2006, Francoeur et al. 2004, Ruemmele et al. 
1999, Wang et al. 2006, Warhurst et al. 1998).  
Interestingly, the pro-apoptotic effect of pro-inflammatory cytokines was only observed 
with myofibroblasts isolated from normal mucosa, myofibroblasts isolated from inflamed 
www.intechopen.com
 
Crohn's Disease 
 
10
mucosa being apoptosis-resistant (Francoeur et al. 2009). Distinct intrinsic properties of 
myofibroblasts isolated from inflammatory bowel disease vs non-inflammatory bowel 
disease patients remains to be elucidated but is not without precedent (Lawrance et al. 
2001). The contribution of bone marrow-derived myofibroblasts in the regenerative process 
in inflammatory bowel disease (Andoh et al. 2005, Brittan et al. 2007) may explain the 
resistance to cytokine-mediated apoptosis.  
The high levels of TGF in the inflamed mucosa may need to be further investigated 
considering its anti-inflammatory effect in inflammatory bowel diseases (Fiocchi 2001) and 
its promoting effect on myofibroblast differentiation (Simmons et al. 2002). Indeed, although 
not directly tested on myofibroblasts for apoptosis, TGF was found to significantly enhance 
SMA expression in intestinal myofibroblasts while all other cytokines reduced SMA 
expression. Interestingly, TGF completely reversed the down-regulation of SMA 
expression triggered by individual proinflammatory cytokines but failed to prevent the 
SMA down-regulation induced by the TNF/IFN combination, suggesting a 
dedifferentiation mechanism (Francoeur et al. 2009). 
In summary, these studies showed that the myofibroblasts of the intestinal pericryptal 
sheath are a target for proinflammatory cytokines in active inflammatory bowel diseases. 
The disappearance of laminin LM-211 and tenascin-C in the pericryptal region of the 
inflamed CD mucosa appears to be a direct consequence of the alteration of the 
myofibroblastic sheath. While proinflammatory cytokines appear to be responsible for the 
net reduction of the number of pericryptal myofibroblasts, the mechanisms involved include 
caspase-dependent apoptosis and dedifferentiation toward a fibroblastic phenotype. 
 
 
Fig. 4. Functional alterations of human intestinal epithelial-stromal components resulting 
from the synergistic effects of TNF and IFN. The TNF/IFN combination was found to 
trigger myofibroblast caspase-dependent apoptosis and myofibroblast dedifferentiation, 
which results in the disappearance of a significant portion of the pericryptal sheath (1) and, 
concomitantly, the loss of two extracellular matrix molecules specifically synthesized by 
these cells: laminin LM-211 and tenascin-C (Tn-C) (2). The TNF/IFN combination was 
found to also elicit caspase-dependent apoptosis in epithelial crypt cells (3) as well as 
induction of the expression of the laminins LM-332 and LM-511 (4), two laminins normally 
not expressed in the lower crypt. Expression of LM-511 may compensate for the 
disappearance of LM-211. 
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4. Conclusions  
It is becoming more and more evident that under inflammatory conditions, the intestinal 
immune response relies on a complex interplay between immune and nonprofessional 
immune cells (Fiocchi 1997b, Macdonald&Monteleone 2005). Proinflammatory cytokines, 
namely TNF and IFN in combination, were shown to induce human intestinal crypt 
epithelial cell apoptosis and altered expression and distribution of laminins LM-332 and 
LM-511 in the crypts (Francoeur et al. 2004), two events that contribute to the disruption of 
epithelial cell homeostasis (Bouatrouss et al. 2000, Teller&Beaulieu 2001). As summarized in 
Fig. 4, the proinflammatory conditions that prevail in the intestinal mucosa of patients 
affected with inflammatory bowel diseases also disrupt the pericryptal sheath, as shown by 
the loss of myofibroblasts and altered expression of laminin LM-211 and tenascin-C 
(Francoeur et al. 2009). Taken together, these data suggest that the entire epithelial-stromal 
interface is affected in the intestine under proinflammatory conditions.  
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